The Global Telehealth Market is likely to expand considerably with impetus from the ability of telehealth to serve the rural population. According to a report published by Fortune Business Insights, titled “Telehealth: Global Market Analysis, Insights, and Forecast, 2019-2026,” the market was valued at US$ 49.8 Bn in 2018. Fortune Business Insights has predicted that the market will reach US$ 266.8 Bn by 2026, thereby exhibiting a CAGR of 23.4%.

Browse Complete Report Details@ https://www.fortunebusinessinsights.com/industry-reports/telehealth-market-101065

Fortune Business Insights highlights some of the prominent telehealth market companies. Some of the leading companies that are operating in the global market are American Well, Teladoc Health, Doctor On Demand, GlobalMed, Dictum Health, Inc., LLC, InTouch Technologies, Inc., MDLIVE Inc., Encounter Telehealth, HelloMD, and SnapMD, Inc.

The ability of telehealth to access and manage healthcare services has led to their rising uptake across the world. Telehealth is used to enhance healthcare services as well as increase feasibility within the healthcare services. Recent technological advancements in telehealth services have created huge potential for growth of the global telehealth market for the forthcoming years. The ability of telehealth services and products to reach out to rural areas and people who cannot access healthcare facilities has created a huge demand across the world. Resulting from such exceptional benefits for telehealth products, investors have identified this market as a gem and have identified several growth opportunities for the telehealth market companies around the world. Additionally, applications of telehealth in improving coordination and communication among the healthcare team will contribute to the increasing demand for telehealth products across the world.

Technological Advancements to Fuel Demand for Telehealth Services

The technological advancements in telehealth products and services have fuelled the demand for telehealth services across the world. The advent of user-friendly systems has contributed to a high demand, which in turn has led to an increase in the global telehealth market value in recent years. In 2019, InTouch announced the launch of a fully integrated end-to-end virtual platform aimed at providing enhanced patient care solutions. ‘Solo’ was a flexible platform integrated with services such as enhanced emergency care solutions, direct-to-patient, and direct-to-customer, which in turn will contribute to the growth of the global telehealth market in the coming years.

The global orthopedic implants market size is set to touch USD 64.0 billion by 2026, exhibiting a modest CAGR of 4.1% during the forecast period. Unprecedented rise in geriatric population across the globe to be the key growth driver of this market. According to the United States Census Bureau (USCB), the proportion of aged people to the total world population is steadily climbing. For example, in 2012, world population had reached 7 billion and the people aged 65 and above were 8% of this number or 562 million.

Browse Complete Report Details@ https://www.fortunebusinessinsights.com/industry-reports/orthopedic-implants-market-101659

Some of the key players in this market include:

• BioTek Instruments, Inc.
• Zimmer Biomet
• Integra LifeSciences Corporation
• DePuy Synthes Companies (Johnson & Johnson Services, Inc.)
• ArthroCare Corporation
• Medtronic
• CONMED Corporation
• Smith & Nephew

In 2015, the number rose by 55 million, with the percentage increasing to 8.5% of the total population in a span of 3 years. The USCB predicts that between 2025 and 2050, this geriatric population will double to reach 1.6 billion, whilst the total population will grow only by 34%.

This, the USCB states, is attributable to the reduction in fertility rates around the world and lengthening lifespans due to advancements in medical technologies. This is expected to substantially broaden the base of the market, especially the joint reconstruction segment, as per the orthopedic implants market trends.

According to the report by Fortune Business Insights, titled “Orthopedic Implants Market Size, Share & Industry Analysis, By Product (Joint Reconstruction; Spinal Implants;Trauma Implants,Dental Implants; Orthobiologics, and Others) End-user (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers, and Others) and Regional Forecast, 2019-2026”, the market value stood at USD 46.5 billion in 2018. The report also incorporates a thorough analysis of the factors, upcoming trends, and dynamics that are likely to influence the growth trajectory of the market. The in-depth research contained in the report aims at equipping businesses with adequate information that will enable them to make informed decisions and strategies for the future.

North America to Hold a Commanding Position; Europe to Grow at an Impressive Rate

Among regions, North America is expected to dominate the global orthopedic implants market share owing to the increasing incidence of osteoarthritis in the region. Europe is projected to grow at a considerable rate on account of rapid spread of chronic diseases such as diabetes and obesity in the continent. In Asia-Pacific, rise in healthcare expenditure and increasing disposable incomes will propel the market in the region, as per the orthopedic implants market analysis by Fortune Business Insights. However, the market growth in Africa, Latin America, and the Middle East is anticipated to be slow due to low levels of development in these regions.

The rising demand from musculoskeletal application segment is prognosticated to help the global magnetic resonance imaging equipment market rise at a positive pace, finds Fortune Business Insights in their new study. The study is titled, “Magnetic Resonance Imaging Equipment Market: Global Market Analysis, Insights and Forecasts, 2018 – 2025.” According to the study, the global magnetic resonance imaging equipment market, which stood at US$ 7,165.6 Mn in 2017, will reach US$ 11,725.9 Mn by the end of 2025. If these figures prove true, the global magnetic resonance imaging equipment market will rise at a CAGR of 6.4% between 2018 and 2025.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/magnetic-resonance-imaging-mri-systems-market-100087

Key Players Operating in The MRI Equipment Market Include:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

• GE Healthcare
• Siemens Healthcare
• Koninklijke Philips N.V.
• Canon Inc.
• Hitachi, Ltd.
• Esaote SpA
• Shenzhen Anke High-tech Co., Ltd.
• Time Medical Holding
• SHENZHEN BASDA MEDICAL APPARATUS CO., LTD.
• Fonar Corporation

The musculoskeletal segment is anticipated to rise at a faster rate among other categories based on application. This is due to the recently proven clinical efficacy of MRI systems in detailed bone imaging cases. Again, the neurology segment, out of various applications will register a higher CAGR because of the expansion of neuroscience in developed nations and its application in medical therapies and testing devices. On the other hand, the hospital segment is likely to generate more revenue over the next few years, because of the significant rise in funding by governments.

Increasing Emphasis of Early Diagnosis to Boost MRI Equipment Market in Latin America

The increasing adoption of MRI systems for detection of severe internal injuries is propelling the MRI equipment market in Asia Pacific. This regional market also exhibits growth at a relatively higher pace. Besides, the increasing incidence of neurological and musculoskeletal disorders and rising number of patient pool will also bode well for the market. Government initiatives for installing new MRI machines in developing economies is likely to boost the market in Asia Pacific.

Strategic Collaborations among Key Players to Give Tailwinds to Growth

Players are entering into strategic collaborations and manufacturing improved MRI systems to gain competitive advantage in the global MRI equipment market. Besides this, they are focusing on mergers and acquisitions, new product launches, and adopting advanced technologies, to strengthen their position in the market. Some of the players operating in the global magnetic resonance imaging equipment market are SHENZHEN BASDA MEDICAL APPARATUS CO., LTD., Shenzhen Anke High-tech Co., Ltd, Hitachi, Ltd., Koninklijke Philips N.V., GE Healthcare, Fonar Corporation, Time Medical Holding, Esaote SpA, Canon Inc, and Siemens Healthcare.

The global genomics market size is projected to reach USD 62614.6 million by 2026. Genomics has successfully transformed the way of preventing, managing and treating diseases. Researchers at the University of Paris-Saclay believe that we have entered into the third revolution of sequencing technology in the world of genetics. Moreover, several companies are planning to build third-generation sequencing technology to stay abreast of new trends. As per a recent report published by Fortune Business Insights, titled “Genomics Market Size, Share and Industry Analysis By Type (Products, Services), Technology (Polymerase Chain Reaction, Next-generation Sequencing, Microarray, Sanger Sequencing), Application (Diagnostics, Research), End-User (Research Institutes, Healthcare Facilities & Diagnostic Centers, Pharmaceutical & Biotechnological Companies, Contract Research Organization (CROs)) & Regional Forecast, 2019 – 2026,” the market value stood at USD 15888.8 million in 2018 and is anticipated to exhibit an exponential CAGR of 18.7% during the forecast period.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/genomics-market-100941

Some of the other leading players operating in the global market are:

• Thermo Fisher Scientific Inc.
• Oxford Nanopore Technologies
• Danaher
• QIAGEN
• BGI
• IntegraGen

The genomics market report outlines the present and future scenario of the market by offering key insights into the trends and drivers stimulating growth. Furthermore, it highlights detailed information on several aspects of the market which include opportunities, challenges, and threats. The report throws lights on the competitive landscape by covering key developments of some of the leading players. It also highlights strategies adopted by players, which in turn, can help stakeholders to make business decisions. Further to this, it also showcases information on all the major segments and their respective market share.

Helix’s New DNA Studio to Aid in Expansion of the Market

Genomics has proved to be successful in the diagnosis of chronic diseases such as cancer. Owing to the increasing prevalence of cancer around the world, the demand for genomics products and services is expected to increase in the forthcoming years. As per the recent genomics market trends, product segment is expected to lead the market in the forecast years. The growth is attributable to the rising use of consumables and increasing number of product launches. For instance, a personal genomics company called Helix announced the launch of a new DNA product studio in October 2018. The aim of this launch is to build and distribute DNA products, thereby benefitting hundreds and thousands of people who want to know how DNA plays a crucial role in wellness and health.

Detailed Table of Content:

1. Introduction

    1.1. Research Scope

    1.2. Market Segmentation

    1.3. Research Methodology

    1.4. Definitions and Assumptions

2.Executive Summary

3.Market Dynamics

    3.1. Market Drivers

    3.2. Market Restraints

    3.3 Market Opportunities

    3.4 Market Trends

4.Key Insights

    4.1GenomicsResearch Spending – For Key Countries, 2018

    4.2RegulatoryScenario – For Key Countries

    4.3Overview of Genomics Service Provider

    4.4New Product Launch

    4.5Start-upswith their Funding Overview

    4.5Key Industry Developments – Mergers, Acquisitions and Partnerships

TOC Continued…

The Global Pulse Oximeters Market is likely to grow in the coming years due to increasing usage clearances from the Food and Drug Administration (FDA). According to a report published by Fortune Business Insights, titled “Pulse Oximeters: Global Market Analysis, Insights and Forecast, 2018-2025,” the market is likely to reach US$ 2,657.6 Mn by the end of 2025. Fortune Business Insights states that the market was valued at US$ 1,587.3 Mn in 2017 and will exhibit a CAGR of 6.7% in the forecast period.

Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/pulse-oximeters-market-100528

Some of the Main Key Players Covered in the Report

• Omron Healthcare, Inc.
• Philips Benelux
• General Electric Manufacturing Company (GEMAC)
• Masimo
• Messe Düsseldorf GmbH
• Vyaire Medical
• Opto Circuits India Ltd.
• Medtronic
• Nonin Medical, Inc

Masimo and Mindray Announce Partnership to Extend Sales Outside the US

In May 2019, Masimo and Shenzhen Mindray Biomedical Electronics announced that they have reached an agreement to extend the distribution of Masimo’s devices. Through this agreement, Mindray will offer sales and distribution options in countries other than the United States. The increasing demand for Masimo’s wrist-worn pulse oximeters has triggered this agreement, which in turn is likely to favor growth of the global market in the forthcoming years.

The report profiles several companies operating in the market and studies their growth strategies with regards to product launches and strategic collaborations. This is intended at evaluating the impact of these strategies on the overall market.

Masimo’s Approval for Radius PPG to Trigger Growth

In 2019, Masimo received clearance for its latest pulse oximeter. The ‘Radius PPG’ was approved by the FDA after establishing efficient results through clinical trials. The Radius PPG represents a significant breakthrough in the healthcare industry, particularly for the diagnosis and study of oxygen levels in the blood. The wireless ability allows users to move freely even when they are being examined with the device.

The Global Telehealth Market is likely to expand considerably with impetus from the ability of telehealth to serve the rural population. According to a report published by Fortune Business Insights, titled “Telehealth: Global Market Analysis, Insights, and Forecast, 2019-2026,” The Global Telehealth Market was valued at US$ 49.8 Bn in 2018. Fortune Business Insights has predicted that the market will reach US$ 266.8 Bn by 2026, thereby exhibiting a CAGR of 23.4%.

Browse Complete Report Details@ https://www.fortunebusinessinsights.com/industry-reports/telehealth-market-101065

Key players leading the global Telehealth Market include

• American Well,
• Teladoc Health,
• Doctor On Demand,
• GlobalMed,
• Dictum Health, Inc., LLC,
• InTouch Technologies, Inc.,
• MDLIVE Inc.,
• Encounter Telehealth,
• HelloMD,
• SnapMD, Inc.

The ability of Telehealth Market to access and manage healthcare services has led to their rising uptake across the world.  Telehealth is used to enhance healthcare services as well as increase feasibility within the healthcare services. Recent technological advancements in telehealth services have created huge potential for growth of the global telehealth market for the forthcoming years. The ability of telehealth services and products to reach out to rural areas and people who cannot access healthcare facilities has created a huge demand across the world. Resulting from such exceptional benefits for telehealth products, investors have identified this market as a gem and have identified several growth opportunities for the telehealth market companies around the world. Additionally, applications of telehealth in improving coordination and communication among the healthcare team will contribute to the increasing demand for telehealth products across the world.

Technological Advancements to Fuel Demand for Telehealth Services

The technological advancements in telehealth products and services have fuelled the demand for telehealth services across the world. The advent of user-friendly systems has contributed to a high demand, which in turn has led to an increase in the global telehealth market value in recent years. In 2019, InTouch announced the launch of a fully integrated end-to-end virtual platform aimed at providing enhanced patient care solutions. ‘Solo’ was a flexible platform integrated with services such as enhanced emergency care solutions, direct-to-patient, and direct-to-customer, which in turn will contribute to the growth of the global telehealth market in the coming years.

According to the World Bank, approximately 84% populace in Germany depend on Internet and around 75% populace in the U.S. are subscribers of the Internet, which augments the global ePharmacy market growth. Fortune Business Insights states that the global ePharmacy market is projected to reach US$ 177,794.9 Mn by 2026, thereby exhibiting an impressive CAGR of 17.3% during the forecast period (2019-2026). The company further states that the global market was valued at US$ 49,727.7 Mn in 2018. According to a published report by Fortune Business Insights, titled, “ePharmacy: Global Market Analysis, Insights and Forecast, 2019-2026,” the global ePharmacy market will witness notable growth during the forecast period due to the technological advancements based on artificial intelligence.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/epharmacy-market-100238

Fortune Business Insights has profiled some of the prominent market players operating in the global ePharmacy market. They are as follows:

• DocMorris
• CVS Health Corporation
• Express Script Holding Company
• Walgreen Co.
• Optum Rx, Inc.
• Giant Eagle, Inc.
• Walmart Stores, Inc.
• Rowland Pharmacy
• The Kroger Co.
• Other players

Increasing Adoption of E-commerce Websites to Favor Growth in Asia Pacific

Geographically, the global ePharmacy market is grouped into Asia Pacific, North America, the Middle East and Africa, Europe, and Latin America. Out of these regions, North America is expected to remain in the leading position in the global ePharmacy market during the forecast period. The growth is attributed to the rapid shift of consumers towards online retailers from offline pharmacies. Also, increasing usage of smartphones and high speed of the Internet are expected to aid North America in gaining the highest global ePharmacy market share in the forthcoming years. Furthermore, a rise in geriatric population, increasing online orders, and growing adoption of online platforms will drive the market growth in this region.

Some major points from Table of Content:

1. Introduction
   • Research Scope
   • Market Segmentation
   • Research Methodology
   • Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
   • Market Drivers
   • Market Restraints
   • Market Opportunities
4. Key Insights
   • Key Start-ups and Funding Overview
   • Key Industry Developments – Mergers, Acquisitions, and Partnerships, 2018
   • Overview of Regulatory Scenario – Key Countries
   • Key Industry Trends
   • Overview of e-Commerce Penetration – Key Countries

TOC Continued….

The global medical equipment financing market size is predicted to reach USD 210.46 billion by 2027 owing to the advent of technological innovations in medical equipment. With the continuous advancement in medical technology, it has become a necessity to opt for the best-in-class medical equipment for excellent healthcare services. However, advanced diagnostic systems are expensive and are difficult for medical practitioners and hospitals to afford through their funds. There arises the need for medical equipment funding with low monthly installments and flexible loan models. According to a recently published report by Fortune Business Insights™ titled, “Medical Equipment Financing Market” Size, Share & Industry Analysis, By Device Type (Diagnostic Equipment, Therapeutic Equipment, Patient Monitoring Equipment, and Others), By End User (Hospitals & Clinics, Laboratories and Diagnostic Centers, and Others), and Regional Forecast, 2020-2027,” the market value was USD 102.30 billion in 2019 and will rise at a CAGR of 9.5% between the forecast duration, 2020 to 2027

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/medical-equipment-financing-market-102731

List of Players Operating in this Market include:

• National Funding
• First American Equipment Finance
• HDFC Bank Ltd
• Hero FinCorp
• Blue Bridge Financial, LLC.
• TIAA Bank
• SMC
• Other Players

What are the Objectives of the Report?

The report is based on an in-depth analysis of the market and focusses on major drivers, restraints, challenges, and upcoming opportunities. It also throws light on the competitive landscape of the market, list of players operating in the market, and the key strategies adopted by them to earn a competitive edge in the market. The report further discusses major industry development, current medical equipment financing market trends, and other interesting insights into the market. Furthermore, the report is available for sale on the company website.

Market Drivers

Advent of Artificial Intelligence into Medical Sector will Add Impetus to Market

Various factors are responsible for the medical equipment financing market growth. These include the increasing number of diagnostic tests, patient monitoring, and increasing demand for diagnostic and therapeutic devices. Besides this, the rising prevalence of infectious diseases is also boosting the market. This, coupled with the rising need to provide advance medical care to patients and the need for therapeutic equipment such as ventilators, dialysis machines, ICU equipment, and others, is further expected to aid in the expansion of the market during the forecast period.

Competitive Landscape:

String Portfolio helped National Funding and Hero FinCorp Cover Dominant Shares

The global medical equipment financing market witnesses the presence of multiple vendors which further intensifies the market competition. However, companies such as Hero FinCorp, and National Funding have established a leading position owing to their affordable financial solutions, acquisition policies, and excellent customer-provider relationships. Apart from this, these players have a well-established portfolio and offer low monthly installments and varied loan options to medical practitioners. Other players are engaging in collaborative efforts such as contracts and agreements, joint ventures, and others to attract high medical equipment financing market revenue in the coming years.

The global prefilled syringes market size is projected to reach USD 9.53 billion by 2026, exhibiting a CAGR of 10.4% during the forecast period. Rising incidence of cancer and other Non-Communicable Diseases (NCDs) is expected to be the primary factor fueling the prefilled syringe market growth. According to the World Health Organization (WHO), 9 million deaths are caused by cancer worldwide every year. In total, NCDs cause close to 41 million deaths, or 71% of the global deaths, annually, states the WHO.

The National Cancer Institute estimates that in the US alone, 1,735,530 new cancer cases were reported in 2018; by 2030, this figure is anticipated to reach 23.6 million. Such widespread prevalence of cancer and other NCDs has generated the need for alternative solutions such as biological drugs. The administration of these drugs requires modern devices such as prefilled syringes, which is foreseen to augment the prefilled syringes market potential in the forthcoming years.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/prefilled-syringes-market-101946

Top Players Identified in the Prefilled Syringe Market Report:

• BD
• Gerresheimer AG
• AptarGroup, Inc.
• Helvoet Rubber & Plastic Technologies BV
• West Pharmaceutical Services Inc.
• SCHOTT AG
• Terumo Corporation
• Nipro PharmaPackaging International
• Other Prominent Players

Europe to Lead the Pack; Asia-Pacific to Grow at a Remarkable Pace

Among regions, Europe is slated to dominate the prefilled syringes market share during the forecast period, with the region’s market size having stood at USD 1.76 billion in 2018. Factors propelling the market in Europe include growing uptake of self-injectable drug devices and increasing preference for biological drugs for treating chronic diseases.

Asia-Pacific is forecasted to showcase high-paced growth on account of increasing prevalence of chronic diseases and a speedily growing patient population. North America is projected to hold the second-largest section of the prefilled syringe market share owing to a strong presence of major market players and rising incidence of cancer.

Product Diversification to be the Focus Area for Competitors

Key players are putting in place different measures to gain a competitive edge, according to the prefilled syringes market analysis. While some companies are looking for ways to widen their product offerings, other participants are engaging in merger and acquisition activities to expand their presence in the market.

The global orthopedic devices market is set to gain traction from the ever-increasing geriatric population across the world. As per a research published in 2015 by the United Health Foundation, every year, more than 300,000 adults belonging to the age group of 65 years and above are estimated to be hospitalized for hip fractures. Besides, around 30% of seniors fall per year. It is further leading to higher number of orthopedic injuries. Fortune Business Insights™ published this information in a recent study, titled, “Orthopedic Devices Market Size, Share & Industry Analysis, By Type (Joint Reconstruction Devices, Spinal Devices, Trauma Devices, Dental Implants, Orthobiologic Devices, Arthroscopy Devices, and Others), By End User (Hospitals, Orthopedic Clinic, Ambulatory Surgical Centers, and Others), and Regional Forecast, 2019-2026.” The study further mentions that the orthopedic devices market size stood at USD 51.33 billion in 2018 and is projected to reach USD 71.67 billion by 2026, thereby exhibiting a CAGR of 4.3% during the forecast period.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/orthopedic-devices-market-102586

Fortune Business Insights™ presents a list of all the companies operating in the orthopedic medical devices market. They are as follows:

• Smith & Nephew
• Stryker
• Zimmer Biomet
• Medical Devices Business Services, Inc. (Johnson & Johnson)
• NuVasive, Inc.
• Medtronic
• Integra LifeSciences
• Wright Medical Group N.V.
• Össur Corporate
• Globus Medical
• Other prominent players

Drivers & Restraints-

Rising Prevalence of Musculoskeletal Diseases to Drive Growth

The American Academy of Orthopedic Surgeons, a provider of educational programs for allied health professionals and orthopaedic surgeons, published a report that affirms that every year in the Unites States alone, approximately 6.8 million patients suffering from several orthopedic injuries come to medical attention. It proves that the rising prevalence of orthopedic injuries and musculoskeletal diseases is further resulting in agonizing physical pain and limited mobility. It is expected to propel the orthopedic devices market growth during the forthcoming years. However, the surgical procedure is very expensive in nature. It may hamper the growth of the market.

Segment-

Joint Reconstruction Segment to Lead Backed by Increasing Number of Surgical Procedures

Based on type, the market is grouped into joint reconstruction devices, dental implants, trauma devices, spinal devices, orthobiologic devices, arthroscopy devices, trauma devices, and others. Out of these, in 2018, the joint reconstruction segment held 35.8% in terms of orthopedic devices market share and is anticipated to lead the market throughout the forecast period. This growth is attributable to the rising number of procedures, namely, extrementies and shoulder reconstructions, hip and knee replacements, and other similar procedures associated with joints. The arthroscopy devices segment is likely to expand at fast pace owing to the increasing emergence of novel products and upsurging cases of soft tissue injuries related to sports.